CellFAB One Series: All-In-One Fully Automated Cell Therapy Development & Production Systems

Scaling cell therapy manufacturing requires balancing strict contamination controls with process flexibility. Moving away from manual protocols toward fully closed, automated systems reduces human error and operator exposure while maintaining product integrity across every unit operation. Integrating steps—from initial PBMC isolation and magnetic bead selection to expansion and final fill-finish—onto a single platform streamlines production and lowers facility overhead. Modular designs accommodate both micro- and nano-sized bead selection methods, allowing teams to adapt parameters for diverse cell types without sacrificing traceability or cleanroom standards. Built-in user controls and 21 CFR Part 11 readiness ensure robust compliance throughout clinical and commercial development. Download the brochure to explore system configurations and learn how closed automation can optimize your cell manufacturing workflow.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.